Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Pfizer

    Tag: pfizer

    You Searched For "Pfizer"
    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Medical Dialogues Bureau28 July 2019 9:17 AM IST
    Sales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
    Pfizer gets USFDA nod for biosimilar to Rituximab

    Pfizer gets USFDA nod for biosimilar to Rituximab

    Medical Dialogues Bureau25 July 2019 8:59 AM IST
    Ruxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
    Trump administration scraps key plan to reduce US drug prices

    Trump administration scraps key plan to reduce US drug prices

    Medical Dialogues Bureau12 July 2019 9:00 AM IST
    The decision represents a new setback to U.S. President Donald Trump's efforts to deliver on a pledge to lower drug prices for consumers before the...
    Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board

    Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board

    Medical Dialogues Bureau5 July 2019 9:10 AM IST
    In a letter to Gottlieb, Warren, who is seeking the Democratic nomination for the 2020 presidential election, said "this kind of revolving door...
    GSK offers concessions to address Pfizer deal concerns

    GSK offers concessions to address Pfizer deal concerns

    Farhat Nasim23 Jun 2019 8:59 AM IST
    GSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
    GSK eyes sale of $1.2 billion consumer health drugs; says report

    GSK eyes sale of $1.2 billion consumer health drugs; says report

    Medical Dialogues Bureau22 Jun 2019 8:59 AM IST
    GSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
    GSK forms drug discovery alliance with University of California CRISPR researchers

    GSK forms drug discovery alliance with University of California CRISPR researchers

    Medical Dialogues Bureau14 Jun 2019 12:24 PM IST
    British drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of...
    Sanofi loses German patent case against Amgen over cholesterol drug Praluent

    Sanofi loses German patent case against Amgen over cholesterol drug Praluent

    Medical Dialogues Bureau9 Jun 2019 9:30 AM IST
    In the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that...
    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    Medical Dialogues Bureau8 Jun 2019 10:00 AM IST
    The price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough...
    Pfizer epilepsy drug Lyrica fails in phase III trial

    Pfizer epilepsy drug Lyrica fails in phase III trial

    Medical Dialogues Bureau28 May 2019 9:00 AM IST
    New Delhi: Pfizer Inc. recently announced that a Phase 3 study to assess the use of LYRICA (pregabalin) as adjunctive therapy for epilepsy patients 5...
    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Meghna A Singhania26 May 2019 6:13 PM IST
    Shanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    Garima25 May 2019 9:45 AM IST
    After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok